CCIA
XERS icon

Campbell & Co Investment Adviser’s Xeris Biopharma Holdings XERS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Buy
21,029
+1,002
+5% +$6.4K 0.01% 988
2026
Q1 		$116K Sell
20,027
-27,427
-58% -$182K 0.01% 999
2025
Q4 		$373K Sell
47,454
-56,162
-54% -$442K 0.02% 923
2025
Q3 		$843K Sell
103,616
-28,766
-22% -$191K 0.06% 489
2025
Q2 		$618K Buy
+132,382
New +$607K 0.04% 712

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Campbell & Co Investment Adviser's XERS Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Xeris Biopharma Holdings (XERS) stake by 5% in Q2 2026, buying an estimated $6.4K and bringing the position to 21,029 shares worth $167K. The position accounts for 0.01% of the portfolio, ranked #988.

Campbell & Co Investment Adviser first reported a position in XERS in Q2 2025 and has held it in 5 quarters since. The position peaked at $843K in Q3 2025. 78 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Campbell & Co Investment Adviser held 21,029 shares of Xeris Biopharma Holdings worth $167K as of Q2 2026.
  • Campbell & Co Investment Adviser bought 1,002 Xeris Biopharma Holdings shares in Q2 2026, an estimated $6.4K.
  • Xeris Biopharma Holdings made up 0.01% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #988 holding.
  • Campbell & Co Investment Adviser first reported a position in Xeris Biopharma Holdings in Q2 2025 and has held it in 5 quarters since.
  • Campbell & Co Investment Adviser's Xeris Biopharma Holdings position peaked at $843K in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.